ArticleResuscitation plus2025
Association between fibrinogen levels and mortality following cardiopulmonary resuscitation: a retrospective cohort study.
Article in Resuscitation plus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac arrest (CA) is a critical condition that would cause high mortality. Fibrinogen, as a macromolecular protein involved in both inflammatory response and coagulation regulation, was reported to be associated with a series of life-threatening conditions. The aim of this study is to investigate the association between fibrinogen level and prognosis of patients after cardiac arrest. Methods: This study is a retrospective study utilizing the database MIMIC-IV version 1.0. Logistic regression and Cox proportional hazards regression were applied to explore the relationship between fibrinogen and in-hospital, 30-day, 90-day mortality of patients after cardiac arrest. Kaplan-Meier survival curve was also drawn. Subgroup analysis was conducted to explore whether the association remains in various subgroups. In addition, propensity score matching (PSM) was used to adjust confounding factor. Results: 525 eligible patients were enrolled in total. Among them, 238 patients survived and 287 died during ICU hospitalization. Kaplan-Meier curve showed significant difference in survival probability ( Conclusion: The presence of reduced fibrinogen level indicates a heightened risk of mortality in patients after cardiac arrest, whereas elevated fibrinogen level may be not associated with mortality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.